BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld
BioWorld
April 4, 2016
View Archived Issues
Complementary approaches yield new target insights
By combining two types of genomic technologies to probe the targets of an experimental antiviral drug, researchers have identified a strategy that may be able to mitigate its toxicity.
Read More
Week in review
Read More
Week in Washington
Read More
Word on the street
Read More
Biotech money raised by month in 2016
Read More
Public financing of biotechnology companies: Commenced trading in March 2016
Read More
Public financing of biotechnology companies: Filed and pending IPOs
Read More
2016 top private financings of public companies
Read More
Other financings of public biotechnology companies: March 2016
Read More
2016 top financings of private companies
Read More
Venture capital & other investments in private biotechnology companies: March 2016
Read More
Milestone payments from corporate partners: March 2016
Read More
Money raised by biotech in 2016 vs. 2015
Read More
Money raised by biotech: Jan. 1 - Mar. 31, 2016
Read More
The week's biggest gainers and losers
Read More
BioWorld stock report for public biotechnology companies
Read More
BioWorld Stock Index 2016
Read More
Nasdaq Stock Index 2016
Read More
